Le Lézard
Classified in: Health, Science and technology
Subjects: PDT, FDA

Ketryx Unveils the First Connected Lifecycle Software for MedTechs


Accelerates bringing FDA-approved life-saving innovations to patients 3x faster

SOMERVILLE, Mass., May 16, 2023 /PRNewswire/ --  Ketryx, the creator of the first connected lifecycle management software for MedTechs, today announced new usability and productivity updates to its flagship software.

Recent guidance from the FDA on cybersecurity, AI/ML, and increasing connectivity of healthcare has made it all the more challenging for MedTechs to balance compliance efforts with the speed and execution that modern software demands.

"Our objective in founding Ketryx is to help companies deliver life-changing innovations faster," said Erez Kaminski, founder and CEO. "We've zeroed in on the complex FDA processes that slow and even preclude many MedTechs from entering the market in the first place. We see an urgent need to help manufacturers leverage their AI/ML and cloud-based environments to deliver their breakthrough products faster, more reliably, and at lower cost."

Funded by MIT, Ketryx is the first and only software solution that unifies existing on-premise and cloud-based tools in MedTech environments to become a living part of the development process. From design to post-launch, Ketryx records data directly from the different systems used to build the product and automatically creates documentation for the FDA for traceability and compliance purposes. Teams can use the tools they love while eliminating tedious, error-prone copying and pasting of information back and forth between systems.

By overlaying built-in intelligence and AI onto safety-critical software environments, Ketryx helps MedTechs dramatically improve efficiency, process control, and traceability. For example:

"Without the use of such approaches as Ketryx, manufacturers are stuck using legacy, standalone tools, making it harder for teams to collaborate and create the modern and life-changing software solutions they are capable of building," said Kaminski.

About Ketryx
Ketryx is the first and only Connected Lifecycle Management software for MedTech that creates traceability across the application lifecycle. Compliant by design, Ketryx embeds guardrails to eliminate the manual, error-prone copying and pasting from traditional disconnected medical systems to reduce the risk of defects while delivering enhanced patient outcomes. Visit us at www.ketryx.com or view a demo at demo.ketryx.com.

All trademarks are the property of their respective holders.

SOURCE Ketryx


These press releases may also interest you

at 13:00
The "PEGylated Proteins Market 2023-2028" report has been added to ResearchAndMarkets.com's offering. The global market for PEGylated proteins is expected to grow from $10.2 billion in 2023 and is projected to reach $15.9 billion by the end of...

at 12:59
UltraSense Systems, an emerging leader in automotive semiconductor Human Machine Interface (HMI) Controllers and HMI touch system designs, will be showcasing how its TouchPoint Q Controller adds force sensing to multiple sizes of off-the-shelf touch...

at 12:55
San Diego Angel Conference (SDAC) at the University of San Diego (USD), a program in its sixth year that activates accredited angel investors and engages promising early-stage companies, today awarded two startups with angel funding for their...

at 12:51
Dr. Scott Kamelle, a trailblazer in the realm of robotic surgery, begins his work with the highly anticipated Da Vinci 5 robotic surgery system, marking a monumental advancement in surgical precision, efficiency, and patient care. With an array of...

at 12:40
Kooler Garage Doors, a leader in providing premium garage door services across the Western Slope of...

at 12:35
Ryan, a leading global tax services and software provider, has been named a Best Place to Work in Illinois for the 13th year, receiving first place in the Large Company category. The annual program, presented by the Best Companies Group and published...



News published on and distributed by: